Matsumoto Yushi Pharmaceutical Co., Ltd. Securities Report - 88th Period (2025/04/01 - 2026/03/31)

Matsumoto Yushi Pharmaceutical Co., Ltd. Securities Report - 88th Period (2025/04/01 - 2026/03/31)

Matsumoto Yushi Pharmaceutical Co., Ltd. has published its 88th period securities report. This report details the company's performance and financial situation from April 1, 2025, to March 31, 2026.

The company's main business is the manufacture and sale of oil products and pharmaceuticals. The report includes financial information such as revenue, expenses, assets, liabilities, and cash flow, making it an important information source for investors and stakeholders.

The company pursues technological innovation and quality improvement, providing products that meet customer needs. In the 2025 annual securities report, the company clearly outlines its strategy aimed at sustainable growth and increased transparency.

The publication of this report allows investors and stakeholders to understand the company's financial situation and use it for future investment decisions. It may also influence market trends.